Skip to content
HowShorted

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2022

In 2022, HTG MOLECULAR DIAGNOSTICS, INC's disclosed short interest ran from 0.95% of shares outstanding on 14 Jan 2022 to 1.52% on 15 Nov 2022, a change of +0.57 percentage points. The year's high was 3.34% on 14 Oct 2022 and its low 0.32% on 15 Mar 2022, averaging 1.33% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.14 days on 14 Oct 2022. Full history: HTG MOLECULAR DIAGNOSTICS, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for HTG MOLECULAR DIAGNOSTICS, INC in 2022

2022 in figures

Start of year
0.95% (14 Jan 2022)
End of year
1.52% (15 Nov 2022)
Change
+0.57 pp
High
3.34% (14 Oct 2022)
Low
0.32% (15 Mar 2022)
Average
1.33%
Highest days to cover
4.14 (14 Oct 2022)
SEC filings marked
9

Every report in 2022

HTG MOLECULAR DIAGNOSTICS, INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20220.95%2.05results (8-K)
31 Jan 20220.50%1.00
15 Feb 20220.36%1.00
28 Feb 20220.33%1.00
15 Mar 20220.32%1.00
13 May 20220.75%1.0010-K filed, results (8-K), 10-Q filed, results (8-K)
15 Jun 20221.75%1.00
15 Aug 20221.44%1.00results (8-K), 10-Q filed
31 Aug 20221.47%1.00
15 Sep 20221.48%1.00
30 Sep 20222.21%2.57
14 Oct 20223.34%4.14
31 Oct 20222.24%2.79
15 Nov 20221.52%2.6010-Q filed, results (8-K)

See also: HTG MOLECULAR DIAGNOSTICS, INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.